Spadafore ADHD Rating Scale
Links shared publicly online about this topic
Spadafore ADHD Rating Scale: The Spadafore ADHD Rating Scale (S-ADHD-RS) is used for children ages five to nineteen ... http://bit.ly/1TF4V7
bit.ly — “Spadafore ADHD Rating Scale: The Spadafore ADHD Rating Scale (S-ADHD-RS) is used for children ages five to nineteen ... http://bit.ly/1TF4V7” View full resource at bit.ly
Most Recently Shared on November 11, 2009 at 7:13 pm By:
Spadafore ADHD Rating Scale: The Spadafore ADHD Rating Scale (S-ADHD-RS) is used for children ages five to nineteen ... http://bit.ly/1TF4V7
Rating Scales and Checklists
help4adhd.org — “Rating Scales and Checklists” View full resource at help4adhd.org
Most Recently Shared on November 17, 2009 at 2:41 am By:
Laura Rolands, Attention and Productivity Coach Health Professional
Wondering if you might have ADHD? National Resource Center on AD/HD has rating scale examples http://bit.ly/QjDuJ
Vanderbilt ADHD Rating Scale clinically useful for detecting learning disorders in children with ADHD
pediatricsupersite.com — “The Vanderbilt Attention-Deficit/Hyperactivity Disorder Rating Scale is a reliable tool for ruling out comorbid reading or spelling learning dis” View full resource at pediatricsupersite.com
Most Recently Shared on October 21, 2010 at 3:55 pm By:
Peter H Brown Doctor and Psychologist
Vanderbilt ADHD Rating Scale clinically useful for detecting learning ... http://bit.ly/cXzJ5P #ADHD
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse
medicalnewstoday.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse&r” View full resource at medicalnewstoday.com
Most Recently Shared on November 14, 2009 at 12:57 pm By:
MNT Psychology News Health News
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse: Shire plc (LSE: SHP, .. http://bit.ly/L7ol7
Shire Reports Findings From An Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse(R) (lisdexamfetamine Dimesylate) Capsules
medicalnewstoday.com — “Shire plc (LSE: SHP, Nasdaq: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse&r” View full resource at medicalnewstoday.com
Most Recently Shared on November 13, 2009 at 1:10 pm By:
MNT Clinical Trials Health News
Shire Reports Findings From An Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse(R) (l.. http://bit.ly/36XeTm
Junk the junk food - NewsTimes
newstimes.com — “Hoffman reported that Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD) in children are regularly determined by using a subjective questionnaire called the Conners' Rating Scale that the parents and teachers fill out. Essentially it was designed as a diagnostic criteria to enroll kids in drug trials, Hoffman said, so it was designed for research and to date it has never been certified by any governing agency in the country. Parents of children with learning and” View full resource at newstimes.com
Most Recently Shared on April 5, 2010 at 8:58 pm By:
Natural Health News! Health News
Junk the junk food http://bit.ly/93DRoB
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse | Psydir News
news.psydir.com — “Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Sc...” View full resource at news.psydir.com
Most Recently Shared on November 14, 2009 at 2:28 pm By:
Shire Reports Analysis Examining Emotional Lability In Children With ADHD Taking Vyvanse http://ow.ly/161DTb
Shire announces findings from Phase 3 study data with Vyvanse
news-medical.net — “Shire plc, the global specialty biopharmaceutical company, announced findings from a post hoc analysis examining emotional lability from Phase 3 study data with Vyvanse®. In this study, Vyvanse demonstrated significant improvement in Attention-Deficit/Hyperactivity Disorder (ADHD) symptoms as measured by the ADHD Rating Scale IV (ADHD-RS IV) and Connors' Parent Rating Scale-Revised Short (CPRS-RS) in children with ADHD aged 6 to 12 years.” View full resource at news-medical.net
Most Recently Shared on November 13, 2009 at 10:12 am By:
Stroke News: Shire announces findings from Phase 3 study data with Vyvanse: Shire plc, the global s.. http://twurl.nl/hs1qon
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Diagnostic_Test
Organizing diagnostic test resources shared by health experts, advocates, and organizations into WisdomCards.
-
Laura Rolands, Attention and Productivity Coach
I coach students & adults w/ attention & productivity challenges like ADHD to overcome challenges, focus & accomplish more. I now offer online coaching!
-
Peter H Brown
Peter H Brown Clinical Psychologist. I'm also a Husband & Dad & wannabe techno-junkie
Advertisement
